Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes
Clinical trial NCT01280682 · COMPLETED
Trial details
- NCT number
- NCT01280682
- Sponsor
- Yang Tao
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2016-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.